Navigation Links
Nventa's CEO to present at two upcoming investor conferences
Date:10/2/2007

SAN DIEGO, CA, Oct. 2 /PRNewswire-FirstCall/ - Nventa Biopharmaceuticals Corporation (TSX:NVN) announced today that Gregory M. McKee, the Company's President and Chief Executive Officer, will present at two upcoming investor conferences:

BioContact Quebec 2007 (Quebec, Canada):

----------------------------------------

Mr. McKee is scheduled to present on Thursday, October 4th at

11:00 am (Eastern Time) in the Salle Laval Room at the Fairmont Le

Chateau Frontenac.

BIO Investor Forum (San Francisco, California):

-----------------------------------------------

Mr. McKee is scheduled to present on Wednesday, October 10th at

1:15 pm (Pacific Time) in the Twin Peaks South Room at the Palace

Hotel in San Francisco. A live webcast with supporting slides of this

presentation will be available via:

http://www.corporate-ir.net/ireye/confLobby.zhtml?ticker=NVN.TO&item_id=1660569

The replay of the webcast at BIO Investor Forum will be available

until January 10, 2008. (Due to its length, this URL may need to be

copied/pasted into your Internet browser's address field. Remove any

extra spaces if necessary.)

About Nventa Biopharmaceuticals Corporation:

--------------------------------------------

Nventa is developing innovative therapeutics for the treatment of viral infections and cancer, with a focus on diseases caused by the human papillomavirus (HPV). The corporation is publicly traded on the Toronto Stock Exchange under the symbol NVN.

For more information about Nventa Biopharmaceuticals Corporation and access to the BIO Investor Forum webcast, please visit the Company's website located at http://www.nventacorp.com.

CONTACT
'/>"/>

SOURCE Nventa Biopharmaceuticals Corporation
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Amplification of genome-representative DNA from limited sources with GenomePlex WGA technology for use in genetic alterations studies
2. Wisconsin firms to present at Cleantech venture capital event
3. New Sonic Foundry search engine finds words, phrases in video presentations
4. Lone Wisconsin firm to present at InvestMidwest
5. Sonic Foundry creates search engine for 7,000 expert video presentations
6. InvestMidWest calls for business presentations
7. Wicab to present BrainPort at Boston conference
8. Three more Wisconsin firms to present at venture forum
9. Six Wisconsin firms to present at BIO Mid-America VentureForum
10. New Health and Human Services representative for Midwest
11. Top 20 big pharmas represent majority of world pharma market
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/18/2013)... , June 18, 2013 ... using the company,s  proprietary AMCA Guided Bone Regeneration (GBR) Dental ... implants. A common problem encountered when patients have ... of sufficient bone volume to house the implant. Consequently there ... bone substitute until the natural bone regenerates. The bone substitute ...
(Date:6/18/2013)... information — Global biopharmaceutical company UCB, Inc. and professional ... of a new Pledge campaign for people with epilepsy ... empowers the millions of Americans living with epilepsy ... to demand more: greater understanding of the condition, better ... seizure control.  More information is available at www.ourtimeourpledge.com ...
(Date:6/18/2013)... , June 18, 2013  AMRI (NASDAQ: ... Burlington, Mass. , site has received ... Administration (DEA) registration to handle Schedule 2 and ... acknowledgement of Burlington,s physical ... documentation. (Logo: http://photos.prnewswire.com/prnh/20120229/NY61160LOGO ) ...
(Date:6/18/2013)... Israel , June 18, 2013 ... Active Pharmaceutical Ingredients (APIs), generic and innovative intermediates, and finished ... that the company has been granted a United ... the US and Europe for the ... number 8,410,176 B2 is titled Intermediate Compounds and Processes ...
Breaking Biology Technology:RegeneCure Starts Clinical Study Using Polymeric Bone Stimulating Membrane for Dental Implants 2RegeneCure Starts Clinical Study Using Polymeric Bone Stimulating Membrane for Dental Implants 3Professional Golfer Jeff Klauk Tees Off New Pledge Campaign for People Living with Epilepsy 2Professional Golfer Jeff Klauk Tees Off New Pledge Campaign for People Living with Epilepsy 3Professional Golfer Jeff Klauk Tees Off New Pledge Campaign for People Living with Epilepsy 4Professional Golfer Jeff Klauk Tees Off New Pledge Campaign for People Living with Epilepsy 5Professional Golfer Jeff Klauk Tees Off New Pledge Campaign for People Living with Epilepsy 6AMRI Burlington Receives DEA Approval to Handle Controlled Substances 2Mapi Pharma Granted United States Patent for Pain Relief Medication "Tapentadol" 2
... Mo., Nov. 7 In refusing to a ... removal and replacement of its,current directors, management of ... developer and manufacturer of diagnostic products whose,American Depository ... that the preservation of their jobs and positions ...
... is an observational study undertaken to evaluate the, ... freezing) techniques, ROCKLAND, Mass., Nov. 7 /PRNewswire/-- ... Darmstadt, Germany, announced the launch of the Human,Oocyte ... Meeting of the American Society for Reproductive Medicine ...
... Calif., Nov. 7 AutoImmune Inc. (OTC,Bulletin Board: AIMM) today ... basic and diluted, for the three months ended September 30, ... per share basic and,diluted, for the three months ended September ... net loss was $216,000, or $0.01 per share,basic and diluted, ...
Cached Biology Technology:Trinity Biotech Management Refuses to Honor Call for a Special Meeting of Shareholders 2Trinity Biotech Management Refuses to Honor Call for a Special Meeting of Shareholders 3EMD Serono Launches Landmark Patient Registry for Egg Freezing 2EMD Serono Launches Landmark Patient Registry for Egg Freezing 3EMD Serono Launches Landmark Patient Registry for Egg Freezing 4AutoImmune Inc. Reports 2008 Third Quarter Financial Results 2AutoImmune Inc. Reports 2008 Third Quarter Financial Results 3
(Date:6/18/2013)... A UT Arlington environmental engineer has been awarded ... District to ensure water quality and flow in ... Project. , Andrew Kruzic, UT Arlington associate professor ... and locations to add monochloramine to the water ... the new pump stations and pipelines. Adding monochloramine ...
(Date:6/18/2013)... $12.7 million to match nine academic research groups ... explore new treatments for patients in eight disease ... schizophrenia. The collaborative pilot initiative, called Discovering New ... the National Center for Advancing Translational Sciences (NCATS) ... The process of developing a new therapeutic is ...
(Date:6/18/2013)... and 10% of breast and ovarian cancers are familial ... are attributable to inherited mutations from the parents in ... these mutations, PARP inhibitors, which are currently in clinical ... new option for personalised cancer treatment, an alternative to ... fraction of these patients generate resistance to the drug ...
Breaking Biology News(10 mins):UT Arlington research to benefit quality, flow in 150-mile Integrated Pipeline 2NIH to fund collaborations with industry to identify new uses for existing compounds 2NIH to fund collaborations with industry to identify new uses for existing compounds 3NIH to fund collaborations with industry to identify new uses for existing compounds 4An article in 'Cell' reveals a new resistance mechanism to chemotherapy in breast and ovarian cancer 2
... looked carefully at the leaves on a plant and noticed ... controls the size and shape of each individual leaf? Very ... and shape, and understanding the mechanisms behind this is a ... size is determined by a combination of cell number, cell ...
... professor of biomedical engineering at NJIT, has received a patent ... is a derivative of isosorbide and may be able to ... including the lining of tin cans. Jaffe has ... Promotion Board (ICPB) in an effort to promote and create ...
... A University of Iowa study supports an earlier UI ... Indiana Harbor and Ship Canal (IHSC) in East Chicago, Ind. ... a significant source of PCBs found in surrounding air and ... edition of the journal Environmental Science and Technology ...
Cached Biology News:Can a single layer of cells control a leaf's size? 2Can a single layer of cells control a leaf's size? 3NJIT patent may be able to replace BPA, make consumer products safer 2UI study measures levels of PCBs flowing from Indiana canal to air and water 2
Blue Standard is 3-cyano-7-hydroxycoumarin....
Cyan Standard is 7-hydroxy-4-trifluoromethylcoumarin...
6-(2,4-dinitrophenyl)aminohexanoic acid, succinimidyl ester (DNP-X, SE)...
Endothelin-converting enzyme 1 (EC 3.4.24.71) (ECE-1). [Source:Uniprot/SWISSPROT;Acc:P42892] Antigen: Recombinant Protein Epitope Signature Tag (PrEST)....
Biology Products: